163 related articles for article (PubMed ID: 16770783)
1. Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy.
Spiess PE; Lee AK; Leibovici D; Wang X; Do KA; Pisters LL
Cancer; 2006 Jul; 107(2):275-80. PubMed ID: 16770783
[TBL] [Abstract][Full Text] [Related]
2. Predictors of biochemical failure in patients undergoing prostate whole-gland salvage cryotherapy: a novel risk stratification model.
Spiess PE; Levy DA; Mouraviev V; Pisters LL; Jones JS
BJU Int; 2013 Aug; 112(4):E256-61. PubMed ID: 23469778
[TBL] [Abstract][Full Text] [Related]
3. Combination of Androgen Deprivation Therapy and Salvage Radiotherapy versus Salvage Radiotherapy Alone for Recurrent Prostate Cancer after Radical Prostatectomy.
Yoo S; You D; Kim YS; Hong JH; Ahn H; Kim CS
Urol Int; 2017; 99(4):406-413. PubMed ID: 29020683
[TBL] [Abstract][Full Text] [Related]
4. Five-Year Biochemical Progression-Free Survival Following Salvage Whole-Gland Prostate Cryoablation: Defining Success with Nadir Prostate-Specific Antigen.
Kovac E; ElShafei A; Tay KJ; Mendez M; Polascik TJ; Jones JS
J Endourol; 2016 Jun; 30(6):624-31. PubMed ID: 26915721
[TBL] [Abstract][Full Text] [Related]
5. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy.
Pisters LL; Leibovici D; Blute M; Zincke H; Sebo TJ; Slezak JM; Izawa J; Ward JF; Scott SM; Madsen L; Spiess PE; Leibovich BC
J Urol; 2009 Aug; 182(2):517-25; discussion 525-7. PubMed ID: 19524984
[TBL] [Abstract][Full Text] [Related]
6. Patient selection for salvage cryotherapy for locally recurrent prostate cancer after radiation therapy.
Pisters LL; Perrotte P; Scott SM; Greene GF; von Eschenbach AC
J Clin Oncol; 1999 Aug; 17(8):2514-20. PubMed ID: 10561317
[TBL] [Abstract][Full Text] [Related]
7. Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer.
Williams AK; Martínez CH; Lu C; Ng CK; Pautler SE; Chin JL
Eur Urol; 2011 Sep; 60(3):405-10. PubMed ID: 21185115
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen after salvage radiotherapy for postprostatectomy biochemical recurrence predicts long-term outcome including overall survival.
Bartkowiak D; Thamm R; Bottke D; Siegmann A; Böhmer D; Budach V; Wiegel T
Acta Oncol; 2018 Mar; 57(3):362-367. PubMed ID: 28816074
[TBL] [Abstract][Full Text] [Related]
9. Salvage radiotherapy for prostate cancer recurrence after cryosurgical ablation.
Burton S; Brown DM; Colonias A; Cohen J; Miller R; Rooker G; Benoit R; Merlotti L; Quinn A; Kalnicki S
Urology; 2000 Nov; 56(5):833-8. PubMed ID: 11068312
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience.
Lee B; Shinohara K; Weinberg V; Gottschalk AR; Pouliot J; Roach M; Hsu IC
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1106-12. PubMed ID: 17197119
[TBL] [Abstract][Full Text] [Related]
11. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.
Stephenson AJ; Shariat SF; Zelefsky MJ; Kattan MW; Butler EB; Teh BS; Klein EA; Kupelian PA; Roehrborn CG; Pistenmaa DA; Pacholke HD; Liauw SL; Katz MS; Leibel SA; Scardino PT; Slawin KM
JAMA; 2004 Mar; 291(11):1325-32. PubMed ID: 15026399
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of salvage prostate cryotherapy stratified by pre-treatment PSA: update from the COLD registry.
Spiess PE; Levy DA; Pisters LL; Mouraviev V; Jones JS
World J Urol; 2013 Dec; 31(6):1321-5. PubMed ID: 23179729
[TBL] [Abstract][Full Text] [Related]
13. A pretreatment nomogram predicting biochemical failure after salvage cryotherapy for locally recurrent prostate cancer.
Spiess PE; Katz AE; Chin JL; Bahn D; Cohen JK; Shinohara K; Hernandez M; Bossier J; Kassouf W; Pisters LL
BJU Int; 2010 Jul; 106(2):194-8. PubMed ID: 19922545
[TBL] [Abstract][Full Text] [Related]
14. Salvage cryotherapy for recurrent prostate cancer after radiation therapy: the Columbia experience.
de la Taille A; Hayek O; Benson MC; Bagiella E; Olsson CA; Fatal M; Katz AE
Urology; 2000 Jan; 55(1):79-84. PubMed ID: 10654899
[TBL] [Abstract][Full Text] [Related]
15. Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome.
Izawa JI; Madsen LT; Scott SM; Tran JP; McGuire EJ; Von Eschenbach AC; Pisters LL
J Clin Oncol; 2002 Jun; 20(11):2664-71. PubMed ID: 12039928
[TBL] [Abstract][Full Text] [Related]
16. Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature.
Nguyen PL; D'Amico AV; Lee AK; Suh WW
Cancer; 2007 Oct; 110(7):1417-28. PubMed ID: 17694553
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen doubling time predicts clinical outcome and survival in prostate cancer patients treated with combined radiation and hormone therapy.
Lee AK; Levy LB; Cheung R; Kuban D
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):456-62. PubMed ID: 15927415
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of prostate specific antigen nadir after salvage cryotherapy.
Greene GF; Pisters LL; Scott SM; Von Eschenbach AC
J Urol; 1998 Jul; 160(1):86-90. PubMed ID: 9628611
[TBL] [Abstract][Full Text] [Related]
19. Local tumor control with salvage cryotherapy for locally recurrent prostate cancer after external beam radiotherapy.
Izawa JI; Perrotte P; Greene GF; Scott S; Levy L; McGuire E; Madsen L; von Eschenbach AC; Pisters LL
J Urol; 2001 Mar; 165(3):867-70. PubMed ID: 11176488
[TBL] [Abstract][Full Text] [Related]
20. Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/ml.
Umezawa R; Ariga H; Ogawa Y; Jingu K; Matsushita H; Takeda K; Fujimoto K; Sakayauchi T; Sugawara T; Kubozono M; Narazaki K; Shimizu E; Takai Y; Yamada S
Radiat Oncol; 2011 Nov; 6():150. PubMed ID: 22053922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
